Latest Security News

Horizon Minerals reported a robust operating cash inflow of A$6 million for Q3 2025, lifting its cash reserves to A$34.4 million. The company also reduced its convertible loan facility balance through partial conversions, maintaining strong liquidity for ongoing exploration.

Asian Battery Metals PLC has successfully raised $6 million through an oversubscribed equity placement, positioning the company to advance exploration and acquisition efforts across its Mongolian battery metals projects.

Kaiser Reef Limited has achieved a 33% increase in processing capacity at its Henty Gold Mine, with ongoing ramp-up activities and exploration efforts aiming to extend mine life and reduce costs.

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.

EPX Limited reported a net increase in Annual Contract Value to $18 million and a steady rise in Annual Recurring Revenue to $15.7 million for Q3 2025, driven by new contracts in the UAE healthcare sector and Australian commercial properties.

Great Southern Mining has won up to $337,500 in government grants to advance drilling at its Duketon Gold and East Laverton projects, aiming to unlock deeper gold and platinum group element deposits.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Noronex Limited has secured a significant earn-in agreement with South32, enabling a A$5 million exploration program at the Cgae Cgae Copper Project in Botswana. This deal expands their strategic alliance and sets the stage for extensive drilling activity in the Kalahari Copper Belt.

Wellnex Life reported an 18.2% sales decline in Q1 FY26 amid delayed IP licensing revenue and increased costs, while securing new debt facilities and exiting the medicinal cannabis segment.